The global substance abuse treatment market encompasses drugs and therapies used for managing withdrawal symptoms and behavioral counseling to treat addictive disorders. Substance abuse refers to the harmful or hazardous use of psychoactive substances like alcohol and illicit drugs. The various treatment options include therapy, medication, and counseling which help people overcome addiction and stabilize their lives. The commonly used drugs for substance abuse treatment include buprenorphine, methadone, disulfiram, naltrexone and acamprosate. Buprenorphine and methadone are used as medication-assisted treatment options while disulfiram, naltrexone and acamprosate are used to help people remain drug-free. Behavioral therapies including cognitive-behavioral therapy, contingency management, and motivational interviewing help treat addictive behavior.

The Global Substance Abuse Treatment Market is estimated to be valued at US$ 11.8 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the global substance abuse treatment market are Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players. The major players are focused on developing innovative products and adopting partnership strategies to expand their Global Substance Abuse Treatment Market Size share.

The rising prevalence of substance abuse disorders across the globe has fueled the demand for effective treatment options. According to WHO, around 276 million people worldwide use drugs at least once a year while 36 million struggle with drug use disorders. The growing social acceptance and legalization of recreational cannabis in some countries has also increased the need for treatment services.

Get More Insights On- Global Substance Abuse Treatment Market Size